Canada markets closed

Helix BioPharma Corp. (HBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.21000.0000 (0.00%)
At close: 03:47PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 48.18M
Enterprise Value 47.40M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)77.46
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -8.02

Trading Information

Stock Price History

Beta (5Y Monthly) -0.74
52-Week Change 30.00%
S&P500 52-Week Change 322.36%
52 Week High 30.2600
52 Week Low 30.1500
50-Day Moving Average 30.1862
200-Day Moving Average 30.2092

Share Statistics

Avg Vol (3 month) 311.96k
Avg Vol (10 day) 36.38k
Shares Outstanding 5229.44M
Implied Shares Outstanding 6229.44M
Float 8179.64M
% Held by Insiders 120.45%
% Held by Institutions 10.00%
Shares Short (Apr 15, 2024) 4449
Short Ratio (Apr 15, 2024) 40.09
Short % of Float (Apr 15, 2024) 40.00%
Short % of Shares Outstanding (Apr 15, 2024) 40.00%
Shares Short (prior month Mar 15, 2024) 42.01k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 31, 2023
Most Recent Quarter (mrq)Oct 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-111.88%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -5.98M
Net Income Avi to Common (ttm)-5.94M
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.64M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.46
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-5.99M
Levered Free Cash Flow (ttm)-7.41M